品名：eraseq® PGT-A Trisomy 13 Reference Material

货号：0720-0777

品牌：SeraCare 

Details

Preimplantation genetic testing (PGT), or preimplantation genetic screening (PGS), both refer to the process of testing 

embryos prior to their transfer into a patient during an in vitro fertilization (IVF) cycle. The aim of the testing is to

screen embryos for genetic anomalies and improve the odds of a successful pregnancy. Preimplantation genetic 

testing for chromosomal aneuploidies (PGT-A) is the most commonly used screening method. 

LGC SeraCare now offers PGT-A reference materials for the most common trisomies - 21, 18, 13 along with euploid 

material which can be used as a negative control. These materials are: 

Formulated as genomic DNA from confirmed trisomic cells in buffer 

Offered at a concentration suitable for PGT-A 

Ideal for introduction to the PGT-A workflow at the WGA step 

Compatible with NGS-based PGT-A assays

维百奥生物代理SeraCare对照及参比物质。

维百奥（北京）生物科技有限公司，自2018年与SeraCare（现隶属于LGC Clinical Diagnostics）合作以来，长期为中国客户

提供包括SeraSeq系列参比物质，领域包括肿瘤、生殖健康和遗传病。SeraCare研发和生产一系列临床参比物质，可以用于任何

研发阶段，以确保临床基因组学检测结果的准确性。

SeraCare参比物质涵盖的范围：

1）Next Generation Sequencing

2）Sanger Sequencing

3）Real-time PCR and digital PCR (dPCR)

4）Microarray

主要特点

1）Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs, 

and RNA fusions

2）Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs

3）Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA 

in plasma, and FFPE

4）Manufactured in cGMP-compliant, ISO 13485-certified facilities

5）Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers